Diagnostic work-up and risk stratification in patients with bladder cancer before and after
treatment must be refined to optimize management and improve outcomes. MRI has been …

Simple Summary Neoadjuvant chemotherapy followed by radical cystectomy is the
recommended standard of care for muscle-invasive bladder cancer patients who are eligible …

Introduction By conducting a systematic review and meta-analysis, we investigated the
prevalence of neuropsychiatric (NP) symptoms among systemic lupus erythematosus (SLE) …

Background Vesical Imaging‐Reporting and Data System (VI‐RADS) is a pathway for the
standardized imaging and reporting of bladder cancer staging using multiparametric (mp) …

Bladder cancer is categorized into nonmuscle-invasive bladder cancer (NMIBC) and muscle-
invasive bladder cancer (MIBC), distinguished by the presence of detrusor muscle invasion …

Abstract Background The Vesical Imaging-Reporting and Data System (VI-RADS) has
demonstrated effectiveness in predicting muscle invasion in bladder cancer before …

Background Bladder urothelial carcinoma is the most prevalent malignancy of the urinary
system worldwide. Accurate staging of bladder cancer, particularly distinguishing between …

Background The Vesical Imaging Reporting and Data System (VI-RADS) has been widely
used for diagnosing muscle-invasive bladder cancer (MIBC), yet instances of misdiagnosis …

Bladder cancer (BC) is common worldwide, and has aggressive features and high rates of
relapse despite treatments. Approximately 30% of patients present with muscle invasive …

Urinary bladder cancer (BC) is one of the most frequent malignancies and the ninth most
common malignancy worldwide. The objective of this study is to assess the role of …